Physician profile
Vance W Brabham
NPI 1447472071
$15,657.06
in general payments reported to CMS, 2019-2025
34 companies · $3,682 in 2025
The $3,682 reported for 2025 was more than what 81% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $683 · 2021: $2,065 · 2022: $3,787 · 2023: $1,534 · 2024: $2,907 · 2025: $3,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730 · Consulting Fee: $2,475 · Travel and Lodging: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,730.44 |
| Consulting Fee | $2,475.00 |
| Travel and Lodging | $1,917.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $5,241.68 | 2020-2025 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $3,913.50 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Shockwave Medical, INC | $3,042.75 | 2021-2025 | |
| Boston Scientific Corporation | $671.49 | 2019-2024 | Eluvia, Ekosonic |
| Inari Medical, INC. | $563.27 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $299.14 | 2019-2024 | Venacure 1470 Pro, Alphavac |
| Medtronic, INC. | $245.29 | 2024-2025 | Endurant Iis |
| Stryker Corporation | $204.72 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $187.91 | 2021-2025 | Repatha, Repatha |
| Silk Road Medical, INC. | $181.01 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Cook Medical LLC | $153.40 | 2020-2025 | Cook, Zilver Ptx |
| Livanova USA, INC. | $117.48 | 2020-2022 | |
| Abbott Laboratories | $115.90 | 2019-2024 | Optis, Diamondback Coronary |
| Edwards Lifesciences Corporation | $82.57 | 2024 | Sapien 3 Ultra Resilia |
| Kerecis Limited | $81.67 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $77.67 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.14 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $67.00 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $59.91 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $46.77 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $37.33 | 2022 | |
| Aroa Biosurgery Incorporated | $24.20 | 2022 | |
| Dilon Technologies, INC. | $23.91 | 2025 | Hemoblast Bellows |
| Acell, INC. | $22.90 | 2020 | |
| Medtronic Vascular, INC. | $21.90 | 2019 | |
| Davol INC. | $18.36 | 2021 | |
| Haemonetics Corporation | $17.30 | 2021 | |
| Argon Medical Devices, INC. | $15.01 | 2022 | |
| Becton, Dickinson and Company | $14.95 | 2025 | Lutonix Drug Coated Balloon |
| Biom'Up France Sas | $14.42 | 2021 | |
| Covidien LP | $13.84 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.67 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Brabham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.